Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Diabetes, Dialysis, Renal & Kidney Disease Companies (Health IT, Devices & Technology)

Hemosphere Inc.

Attachments

*Architects: Diabetes, Dialysis, Renal & Kidney Disease Companies (Health IT, Devices & Technology)
*Architects: Surgical & Diagnostic Technology _ Vascular, PAD (Peripheral Arterial Disease & CLI (Critical Limb Ischemia)
*Industry: Minnesota
Companies: Acquired_(M&A)
Finance & Acquisitions: Cryolife
Kaiser Permanente National Venture Development (#9 Medical Strategic Investment-2005)
Mutual Capital Partners

and Ascension Health Ventures, St. Louis
CryoLife acquires HemoSphere for $17M
Cutlass Capital, Boston
Dialysis is a procedure in which a patient’s blood is removed, cleaned by a machine and then returned to the body.
Doris Engibous, President and CEO of Hemosphere
Eden Prairie, Minnesota
Founded 1989
Has raised more than $9.3 million in equity for its vascular-access device
Hemosphere, Inc. Closes $9.3 Million Financing Kaiser Permanente Ventures is Lead Investor (2010)
HeRO graft, a novel vascular access device, is a fully subcutaneous AV access solution, clinically proven to maintain long-term access for hemodialysis patients with venous outflow obstruction.
Previous institutional investors also participating in this round include Affinity Capital Management, Minneapolis
Sapient Capital, Wilson, Wyo.
The company’s HeRo device is designed for use in patients with chronic kidney disease who’ve suffered damage to their veins. Th
Used by patients undergoing dialysis